Abstract
Inhibitory effect of adenosine on the isolated heart muscle and vascular system were first described in 1929 (1). Since then, numerous reviews have been published on the diverse actions of this nucleoside on a wide variety of cell types. Essentially all effects of adenosine in neurons and non-neuronal cells are mediated by activation of nucleoside membrane receptors coupled to specific intracellular second messenger pathways. This brief review describes two novel actions of adenosine in peripheral sympathetic neurons, which are not mediated by adenosine receptors. First is described how adenosine and related nucleosides are able to induce apoptosis during the initial stages of neuronal growth and development in vitro and in vivo. Second is discussed how adenosine is able to prevent or delay apoptosis in more mature sympathetic neurons subjected to nerve growth factor deprivation in culture. Both the induction and prevention of apoptosis are independent of receptor activation, and totally dependent on the intracellular accumulation and subsequent phosphorylation of adenosine. The physiological significance and mechanisms by which adenosine can induce apoptosis in one situation, and rescue from apoptosis in another, are described in this article.
Similar content being viewed by others
References
Drury A. N. and Szent-Gyorgi A. (1929) The physiological activity of adenine compounds with special reference to their actions upon the mammalian heart. J. Physiol. 68, 213–237.
Knudsen T. B., Gray M. K., Church J. K., Blackburn M. R., Airhart M. J., Kellems R. E., and Skalko R. G. (1989) Early postimplantation embryolethality in mice following in utero inhibition of adenosine deaminase with 2′-deoxycoformycin. Teratology 40, 615–626.
Polmar S. H., Stern R. C., Schwartz A. L., Wetzler E. M., Chase P. A., and Hirschhorn R. (1976) Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N. Engl. J. Med. 295, 1337–1343.
Hirschhorn R., Paageorgiou P. S., Kesarwala H. H., and Taft L. T. (1980) Amerioration of neurologic abnormalities after “enzyme replacement” in adenosine deaminase deficiency. N. Engl. J. Med. 303, 377–380.
Wakade T. D., Palmer K. C., McCauley R., Przywara D. A., and Wakade A. R. (1995a) Adenosine-induced apoptosis in embryonic chick sympathetic neurons: a new physiological role for adenosine. J. Physiol. 488, 123–138.
Wakade A. R., Przywara D. A., Palmer K. W., Kulkarni J. S., and Wakade T. D. (1995b) Deoxynucleoside induces neuronal apoptosis independent of neurotrophic factors. J. Biol. Chem. 270, 17,986–17,982.
Wakade A. R., Wakade T. D., Malhotra R. K., and Bhave S. V. (1988) Excess K+ and phorbol ester activate protein kinase C and support the survival of chick sympathetic neurons in culture. J. Neurochem. 51, 975–983.
Wyllie A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555–556.
Thompson C. B. (1995) Apoptosis in pathogenesis and treatmentof disease. Science 267, 1456–1462.
Zhao Z., Crossland W. J., Kulkarni J. S., Wakade T. D. and Wakade A. R. (1999) 2′-Deoxyadenosine causes cell death in chick embryo sympathetic ganglia and brain. Cell. Tissue Res. 296, 281–291.
Wakade A. R., Guo X., Palmer K. C., Kulkarni J. S., Przywara D. A., and Wakade T. D. (1996) 2′-deoxyadenosine induces apoptosis in rat chromaffin cells. J. Neurochem. 67, 2273–2281.
Schwartz A. L., Stern R. C., and Polmar S. H. (1978) Demonstration of adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency. Clin. Immunol. Immunopathol. 9, 499–505.
Kizake H., Suzuki K., Takakuma T., and Ishimura Y. (1990) Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage. J. Biol. Chem. 265, 5280–5284.
Szondy Z. (1994) Adenosine stimulates DNA fragmentation in human thymocytes by Ca2+-mediated mechanism. Biochem. J. 304, 877–885.
Abbracchio M. P., Saffrey M. J., Hopker V., and Burnstock G. (1994) Modulation of astroglial cell proliferation by analogues of adenosine and ATP in primary cultures of rat striatum. Neuroscience 59, 67–76.
Yao Y., Sei Y., Abbracchio M. P., Jiang J. L., Kim Y. C., and Jacobson K. A. (1997) Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists. Biochem. Biophys. Res. Commun. 232, 317–221.
Plamondon H., Blondeau N., Heurteaux C., Lazdunski M., (1999) Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocamapal neuronal death: involvement of adenosineA1 receptors and K (ATP) channels. J. Cereb. Blood Flow Metab. 12, 1296–1308.
Shneyvays V., Jacobson K. A., Li A. H., Nawrath H., Zinman T., Isaac A., Shainberg A., (2000) Induction of apoptosis in rat cardiocytes by A3 adenosine receptors and its suppression by isoproterenol. Exp. Cell Res. 25, 111–126.
Brambilla R., Cattabeni F., Ceruti S., Barbeieri D., Franceschi C., Kim Y. C., et al. (2000) Activation of the A3 adenosine receptor affects cell cycle progression and cell growth. Naunyn Schmiedebergs Arch. Pharmacol. 361, 225–234.
van Lubitz D. K., Ye W., McClehan J., Lin R. C. (1999) Stimulation of adenosine A3 receptors in cerebral ischemia. Natural death, recovery or both? Ann. NY Acad. Sci. 890, 93–106.
Kull J. S., Fredholm B. B., and Orrenius S., (1996) P2X purinoceptor is not important in thymocyte apoptosis. Immunol. Lett. 49, 197–201.
Thampy K. G., Barnes E. M., Jr. (1983) Adenosine transport by primary cultures of neurons from chick embryo brain. J. Neurochem 40, 874–879.
Kulkarni J. S., Wakade A. R. (1996) Quantitative analysis of similarities and differences in neurotoxicities caused by adenosine and 2′-deoxyadenosine in sympathetic neurons. J. Neurochem. 67, 778–778.
Przywara D. A., Bhave S. V., Chowdhury P. S., Wakade T. D., Wakade A. R. (1993) Sites of transmitter release and relation to intracellular Ca2+ in cultured sympathetic neurons. Neuroscience 52, 973–986.
Mitchell B. S., Mejias E., Daddona P. E. and Kelly W. N. (1978) Purinergic immunodeficiency diseases. Selective toxicity of deoxyribonucleosides for T cells. Proc. Nat. Acad. Sci. USA 75, 5011–5016.
Ceruti S., Barbieri D., Veronese E., Cattabeni F., Cosarizza A., Malorni W., Franceschi C., Abbracchio M. P. (1997) Different pathways of apoptosis revealed by 2-chloroadenosine and deoxy-D-ribose in mammalian astroglial cells. J. Neurosci Res. 47, 372–383.
Ceruti S., Franceschi C., Barbeieri D., Malorni W., Camurri A., Giammarioli A. M., et al. (2000) Apoptosis induced by 2-chloro-adenosine and 2-chloro-2′deoxy-adenosinein a human astrocytoma cell line: differential mechanism and possible clinical relevance. J. Neurosci. Res. 60, 388–400.
Barbieri D., Abbracchio M. P., Salvioli S., Monti D., Cossarizza A., Ceruti S., Brambilla R., and Cattabeni F. (1998) Apoptosis by 2-chloro-2′-deoxy adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem Int. 32, 493–504.
Miller R. L., Adamczyk D. L., Miller W. H., Koszalka G. W., Rideout J. L., Beachman L. M., et al. (1979) Adenosine kinase from rabbit liver. II substrate and inhibitor specificity. J. Biol. Chem. 254, 2346–2352.
Newby A. C. (1981) The interaction of inhibitors with adenosine metabolizing enzymes in intact isolated cells. Biochem. Pharmacol. 30, 2611–2615.
Andres C. M. and Fox I. H. (1979) Purification and properties of human placental adenosine kinase. J. Biol. Chem. 254, 11,388–11,393.
Mlejnek P. and Kuglik P. (2000) Induction of apoptosis in HL-60 cells by N 96)-benzyladenosine. J. Cell Biochem. 77, 6–17.
Davis P. K. and Johnson G. V. (1999) Energy metabolism and protein phosphorylation during apoptosis: a phosphorylation study of tau and high-molecular-weight tau in different PC 12 cell. Biochem. J. 15, 51–58.
Wakade A. R., Kulkarni J. S., and Fujii J. T. (1998) 2′-Deoxyadenosine selectively kills non-neuronal cells without affecting survival and growth of chick dorsal root ganglion neurons. Brain Res. 788, 69–79.
Kulkarni J. S., Przywara D. A., Wakade T. D., and Wakade A. R. (1998) Adenosine induces apoptosis by inhibiting mRNA and protein synthesis in chick embryonic sympathetic neurons. Neruroscience Lett. 248, 167–190.
Planet G. and Fox I. H. (1976) Inhibition of phosphorybosilpyrophosphate synthesis by purine nucleosides in human erythrocytes. J. Biol. Chem. 251, 5839–5844.
Tinton S. A., Chow S. C., Buc-Calderon P., Kass G. E., and Orrenius S. (1995) Adenosine inhibits protein synthesis in isolated rat hepatocytes. Evidence for a lack of involvement of extracellular calcium in the mechanism of inhibition. Eur. J. Biochem. 229, 419–425.
Tinton S. A., Buc-Calderon P. (1995) Homocysteine enhances the inhibitory effect of extracellular adenosine on the synthesis of proteins in isolated rat hepatocytes. Biochem. J. 310, 893–896.
Harrington E. O., Smeglin A., Parks N., Newton J., Rounds S. (2000) Adenosine induces endothelial apoptosis by activating protein tyrosine phosphatase: a possible role of p38alpha. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L733–742.
Liang P. and Pardee A. B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971.
Deckwerth T. L. and Johnson E. M., Jr. (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell. Biol. 123, 1207–1222.
Deshmukh M. and Johnson E. M., Jr. (1997) Programmed cell death in neurons: Focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol. 51, 897–906.
Przywara D. A., Kulkarni J. S., Wakade T. D., Leontiev D. V., and Wakade A. R. (1998) Pituitary adenylyl cyclase-activating polypeptide and nerve growth factor use the proteasome to rescue nerve growth factor-deprived sympathetic neurons cultured from chick embryos. J. Neurochem. 71, 1889–1897.
Matsuoka Y., Okazaki M., Takata K., Kitamura Y., Ohta S., Sekino Y., and Taniguchi T. (1999) Endogenous adenosine protects CA1 neurons from kianic acid-induced neuronal loss in the rat hippocampus. Eur. J. Neurosci. 11, 3617–3625.
Michel P. P., Marien M., Ruberg M., Colpaert F., and Agid Y. (1999) Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism thatinvolves astrocytes. J. Neurochem. 72, 2074–2082.
Vitolo O. V., Ciotti M. T., Galli C., Borsello T., and Calissano P. (1998) Adenosine and ADP prevent apoptosis in cultured rat cerebellar granule cells. Brain Res. 809, 297–301.
Fishman P., Bar-Yehuda S., Ohana G., Pathak S., Wasserman L., Barer F., and Multani A. S. (2000) Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptors. Eur. J. Cancer 36, 1452–1458.
Stefanis L., Park D. S., Yan I., Farinelli S. E., Troy C. M., Shelanski M. L., and Greene L. A. (1996) Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support. J. Biol. Chem. 271, 30,663–30,671.
Armstrong R. C., Aja T. J., Hoang K. D., Guar S., Bai X., Alnemri E. S., et al. (1997) Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J. Neurosci. 17, 553–562.
Eldadah B. A., Yakovelev A. G., and Faden A. I. (1997) The role of CED-3-related cysteine proteases in apoptosis of cerebellar granule cells. J. Neurosci. 17, 6105–6113.
Hoppe J., Schafer R., Hoppe V., and Sachinidis A. (1999) ATP and adenosine prevent via different pathways the activation of caspases in apoptotic AKR-2B fibroblasts. Cell Death Diff. 6, 546–556.
Liu X., Zou H., Slaughter C., and Wang X. (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175–184.
Rydel R. E. and Greene L. A. (1998) cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. Natl. Acad. Sci. USA 85, 1257–1261.
Edwards S. N., Buckmaster A. E., and Tolkovsky A. M. (1991) The death programme in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization. J. Neurochem. 57, 2140–2143.
Martin D. P., Ito A., Horigome K., Lanpe P. A., and Johnson E. M., Jr. (1992) Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J. Neurobiol. 23, 1205–1220.
Villalba M., Bockaert J., and Journot L. (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J. Neurosci. 17, 83–90.
Campard P. K., Crochemore C., Rene R., Monnier D., Koch B., and Loeffler J. P. (1997) PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. DNA Cell Biol. 16, 323–333.
Martin D. P., Schmidt R. E., DiStefano P. S., Lowry O. H., Carter J. G., and Johnson E. M., Jr. (1998) Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106, 829–844.
Cavallaro S., Copani A., D’Agata V., Musco S., Petralia S., and Ventra C., et al. (1996) Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol. Pharmacol. 50, 60–66.
Phillis J. W. and O’Regan M. (1993) Prevention of ischemic brain injury by adenosine receptor activation. Drug Dev. Res. 28, 390–394.
Olah M. E. and Stiles G. I. (1995) Adenosine receptor subtypes: characterization and therapeutic regulation. Ann. Rev. Pharmacol. Toxicol. 35, 581–606.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wakade, A.R., Przywara, D.A. & Wakade, T.D. Intracellular, nonreceptor-mediated signaling by adenosine. Mol Neurobiol 23, 137–153 (2001). https://doi.org/10.1385/MN:23:2-3:137
Issue Date:
DOI: https://doi.org/10.1385/MN:23:2-3:137